IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sumitomo Mitsui Trust Holdings, Inc. | 2,573,091 | $15,721,586 | 0.01% |
| Bank Pictet & Cie (Europe) AG | 37,965 | $231,966 | 0.01% |
| FRANKLIN RESOURCES INC | 2,699,983 | $16,496,896 | 0.01% |
| PRINCIPAL FINANCIAL GROUP INC | 1,912,772 | $11,687,037 | 0.01% |
| WINTON GROUP Ltd | 18,929 | $115,656 | 0.01% |
| Curi RMB Capital, LLC | 34,791 | $212,573 | 0.01% |
| NOMURA HOLDINGS INC | 371,059 | $2,267,170 | 0.01% |
| PICTET ASSET MANAGEMENT SA | 964,292 | $5,891,824 | 0.01% |
| China Universal Asset Management Co., Ltd. | 3,038 | $19 | 0.01% |
| NEW YORK STATE COMMON RETIREMENT FUND | 677,309 | $4,138 | 0.01% |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 71,254 | $435,362 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 57,527 | $351 | 0.01% |
| STATE STREET CORP | 13,733,033 | $83,908,832 | 0.01% |
| MORGAN STANLEY | 7,692,691 | $47,002,342 | 0.01% |
| GOLDMAN SACHS GROUP INC | 3,932,984 | $24,030,532 | 0.01% |
| Nuveen Asset Management, LLC | 2,155,542 | $13,170 | 0.01% |
| CITIGROUP INC | 1,262,645 | $7,714,761 | 0.01% |
| Citadel Advisors | 3,472,031 | $21,214,109 | 0.01% |
| Cresset Asset Management, LLC | 31,000 | $189,410 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 94,041 | $574,591 | 0.00% |
External links
This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q1 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.